Inner Banner

Research Projects

High-risk acute promyelocytic leukemia and novel therapeutics


The project on high-risk Acute Promyelocytic Leukemia (APL) is a comprehensive research endeavor that combines proteomics and genomics to gain a deeper understanding of acquired arsenic trioxide (ATO) resistance. With the use of different APL  models together with novel therapeutic combinations, we aim to overcome ATO resistance.

Back to Top